On June 5, 2019 the U.S. Food and Drug Administration announced the extension of the expiration dates by four months of all lots of EpiPen 0.3 mg Auto-Injectors and its authorized generic version currently on the market in the U.S. This announcement is based on a careful review of product stability data provided by Meridian. The expiration extension will help alleviate the EpiPen 0.3 mg strength shortage situation as Pfizer continues its efforts to increase production. Please review the table listed here to confirm the new expiration date for your EpiPen or epinephrine injection 0.3 mg auto-injectors.
Importantly, patients must continue to adhere to the manufacturer’s expiry date labeled on EpiPen Jr® 0.15 mg and Authorized Generic Epinephrine Injection, USP Auto-Injectors 0.15 mg. The stability data does not support an extension of the expiration date to EpiPen Jr® (epinephrine injection, USP) 0.15 mg Auto-Injectors and its authorized generic version.